Kevin G Hampel

5PUBLICATIONS
20CO-AUTHORS
Cellular nervous systemRheumatology and arthritisCognitionDisease surveillanceBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 28, 2026
Freedon study: Real-life outcomes of cenobamate in different lines of treatment.

Vicente Villanueva, José María Serratosa, Alejandro Fernández-Cabrera

|Oct 29, 2024
BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice.

Vicente Villanueva, Esther González Villar, Alejandro Fernandez-Cabrera

|Nov 03, 2023
Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy.

Judit Catalán-Aguilar, Kevin G Hampel, Irene Cano-López

|May 07, 2023
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program.

Vicente Villanueva, Daniel Santos-Carrasco, Pablo Cabezudo-García

Pageof 1